---
title: Treatment response as surrogate to predict risk for disease progression in
  pediatric medulloblastoma with persistent MRI lesions after first-line treatment
date: '2024-04-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38578306/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240406181050&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Overall response and extent of lesions can function as surrogate
  parameters to predict outcomes in pediatric MB patients with persistent lesions
  after first-line therapy. Especially in case of solitary persistent medulloblastoma
  MRI lesion, additional therapy was not beneficial. Therefore, treatment response,
  extent/kind of residual lesions and further diagnostic information needs consideration
  for indication of additional treatments for persisting ...'
disable_comments: true
---
CONCLUSION: Overall response and extent of lesions can function as surrogate parameters to predict outcomes in pediatric MB patients with persistent lesions after first-line therapy. Especially in case of solitary persistent medulloblastoma MRI lesion, additional therapy was not beneficial. Therefore, treatment response, extent/kind of residual lesions and further diagnostic information needs consideration for indication of additional treatments for persisting ...